Lund Melanoma Study Group
31 – 40 of 245
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Author Reply
Silfverschiöld, Maria LU
; Jarl, Johan
LU
; Hafström, Anna
LU
; Greiff, Lennart
LU
and Sjövall, Johanna
LU
(2024)
In Value in Health
27(10).
p.1468-1468
- Contribution to journal › Letter
-
Mark
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
Faraj Tabrizi, Schayan ; Mei, Wenbin ; Godina, Christopher LU
; Lovisa, Anthea F.
; Isaksson, Karolin
LU
; Jernström, Helena
LU
and Tavazoie, Sohail F.
(2024)
In Cell
188(2).
p.28-389
- Contribution to journal › Article
-
Mark
Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants
Wadt, Karin A.W. ; Harbst, Katja LU
; Sjøl, Mette M.B.
; Rosengren, Frida
LU
; Yde, Christina Westmose
; Rohrberg, Kristoffer Staal
; Jensen, Marlene Richter
; Heegaard, Steffen
; Kiilgaard, Jens Folke
and Gerdes, Anne Marie
, et al.
(2024)
In PLoS ONE
19(10).
- Contribution to journal › Article
-
Mark
Teledermoscopic triage of melanoma-suspicious skin lesions is safe : A retrospective comparative diagnostic accuracy study with multiple assessors
Nervil, Gustav Gede ; Ternov, Niels Kvorning ; Lorentzen, Henrik ; Kromann, Charles ; Ingvar, Åsa LU
; Nielsen, Kari
LU
; Tolsgaard, Martin
; Vestergaard, Tine
and Hölmich, Lisbet Rosenkrantz
(2024)
In Journal of Telemedicine and Telecare
- Contribution to journal › Article
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
Godina, Christopher LU
; Belting, Mattias
LU
; Vallon-Christersson, Johan
LU
; Isaksson, Karolin
LU
; Bosch, Ana
LU
and Jernström, Helena
LU
(2024)
In Scientific Reports
14(1).
- Contribution to journal › Article
- 2023
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
Arance, Ana ; De La Cruz-Merino, Luis ; Petrella, Teresa M. ; Jamal, Rahima ; Ny, Lars ; Carneiro, Ana LU
; Berrocal, Alfonso
; Márquez-Rodas, Ivan
; Spreafico, Anna
and Atkinson, Victoria
, et al.
(2023)
In Journal of Clinical Oncology
41(1).
p.75-85
- Contribution to journal › Article
-
Mark
Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
- Contribution to journal › Article
-
Mark
Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patients
Lyth, Johan ; Mikiver, Rasmus ; Nielsen, Kari LU
; Ingvar, Christian
LU
; Olofsson Bagge, Roger
and Isaksson, Karolin
LU
(2023)
In European Journal of Surgical Oncology
49(10).
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
- Contribution to journal › Article
-
Mark
Factors for not performing total body skin examinations in primary care in association with teledermoscopy
- Contribution to journal › Article